F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma.

Bartel TB, Haessler J, Brown TL, Shaughnessy JD, van Rhee F, Anaissie E, Alpe T, Angtuaco E, Walker R, Epstein J, Crowley J, Barlogie B
Blood. 2009 114 (10): 2068-76

PMID: 19443657 · PMCID: PMC2744568 · DOI:10.1182/blood-2009-03-213280

MeSH Terms (19)

Aged Aged, 80 and over beta 2-Microglobulin Bone Neoplasms C-Reactive Protein Cell Proliferation Disease-Free Survival Female Fluorodeoxyglucose F18 Humans L-Lactate Dehydrogenase Male Multiple Myeloma Neoplasm Metastasis Positron-Emission Tomography Radiography Radiopharmaceuticals Risk Factors Survival Rate

Connections (1)

This publication is referenced by other Labnodes entities: